APH
Wall Street says “still a fan”
JPMorgan just nudged Amphenol’s price target up to $190 from $185 and kept its overweight rating on the stock. Translation: the bank still thinks APH has room to run, even if it’s not exactly screaming from the rooftops.
Why investors care
A small target bump doesn’t sound dramatic, but on a name like Amphenol it can reinforce the “quality compounder” narrative. When analysts keep leaning bullish, it can help support the share price — especially if the market is already wondering whether the stock has gotten a little too cozy near the top of its range.
The plot twist in the fine print
The article also notes that CEO Richard Norwitt sold 515,281 shares, worth about $75.9 million, trimming his ownership by 21.1%. That’s not the same as a company changing its operating outlook, but it’s the kind of thing investors notice because insider selling can make people squint at an otherwise sunny analyst note.
Big picture
For now, the main story is simple: Wall Street still likes Amphenol, and JPMorgan just made that view a little louder. The upside case is intact — but as always, you’ll want to watch whether the stock is trading on fundamentals, analyst love, or just a very expensive handshake.